The unusually high oxidation state + IV of cobalt is stabilized by ligands based on [B11H11]4– in dark blue colored Cs4[Co(B11H10.11(OH)0.75)2]·4.56H2O, K4[Co(B11H9.19(OH)1.81)2]·2H2O, Cs8[Co{(B11H6)2(O)(O2BOH)4}]2·4H2O and K4[Co{(B11H6)2(O2BOH)5}]·7H2O. These compounds were obtained by reacting Co2+ salts with [B11H14]− under alkaline conditions. In the absence of oxygen, Co(+III) compounds such as the light brownish K4[Co(B11H11)(CN)3]·KCl·2.5H2O are formed. The title compounds were characterized by X-ray crystallography. Cs8[Co{(B11H6)2(O)(O2BOH)4}]2·4H2O and K4[Co(B11H11)(CN)3]·KCl·2.5H2O were also characterized using IR-, UV–vis and cyclovoltammetry. Magnetic measurements of Cs4[Co(B11H10.11(OH)0.75)2]·4.56H2O and ESR measurements of Cs8[Co{(B11H6)2(O)(O2BOH)4}]2·4H2O show that in these Co(+IV) low-spin d5 complexes the unpaired electron is on the dx2–y2, dxy (E2g) orbitals.
No takes yet. Share an insight, caveat, or question.
Bernhardt et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: